Phibro Animal Health (PAHC) Misses Q1 EPS by 6c; Offers FY23 Guidance

Phibro Animal Health (NASDAQ: PAHC) reported Q1 EPS of $0.21, $0.06 worse than the analyst estimate of $0.27. Revenue for the quarter came in at $232.5 million versus the consensus estimate of $221.5 million.

GUIDANCE:

Phibro Animal Health sees FY2023 EPS of $1.21-$1.31, versus the consensus of $1.27. Phibro Animal Health sees FY2023 revenue of $0.96-1 billion, versus the consensus of $0.98 billion.

For earnings history and earnings-related data on Phibro Animal Health (PAHC) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Robinhood prices $2B convertible notes offering due 2029
• AeroVironment restates quarterly financials, citing $89M goodwill error